Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer

Journal of Clinical Oncology

Volumn 28, Issue 14, 2010, Pages 2430-2436

  Dikken, Johan L ^a   Jansen, Edwin P M ^a   Cats, Annemieke ^a   Bakker, Berdine ^a   Hartgrink, Henk H ^a   Kranenbarg, Elma Meershoek Klein ^a   Boot, Henk ^a   Putter, Hein ^a   Peeters, Koen C M J ^a   Van De Velde, Cornelis J H ^a   Verheij, Marcel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CISPLATIN; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; STOMACH ADENOCARCINOMA; STOMACH CANCER; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; GASTRECTOMY; KAPLAN MEIER METHOD; METASTASIS; MORTALITY; NETHERLANDS; PATHOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STOMACH TUMOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; GASTRECTOMY; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUCOVORIN; LYMPH NODE EXCISION; MALE; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952470801     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.9654     Document Type: Article

References (32)

1. Kelley JR, Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56:1-9, 2003 (Pubitemid 36183309)
2. Boyle P, Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol 16:481-488, 2005
3. Akoh JA, Macintyre IM: Improving survival in gastric cancer: Review of 5-year survival rates in English language publications from 1970. Br J Surg 79:293-299, 1992
4. Gunderson LL: Gastric cancer: Patterns of relapse after surgical resection. Semin Radiat Oncol 12:150-161, 2002
5. Hartgrink HH, van de Velde CJ, Putter H, et al: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069-2077, 2004 (Pubitemid 41095139)
6. Cuschieri A, Weeden S, Fielding J, et al: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522-1530, 1999 (Pubitemid 29116815)
7. Degiuli M, Calvo F: Survival of early gastric cancer in a specialized European center: Which lymphadenectomy is necessary? World J Surg 30:2193-2203, 2006
8. Krijnen P, den Dulk M, Meershoek-Klein Kranenbarg E, et al: Improved survival after resectable non-cardia gastric cancer in the Netherlands: The importance of surgical training and quality control. Eur J Surg Oncol 35:715-720, 2009
9. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88:921-932, 2000
10. Sant M, Allemani C, Santaquilani M, et al: EUROCARE-4: Survival of cancer patients diagnosed in 1995-1999 - Results and commentary. Eur J Cancer 45:931-991, 2009
11. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001
12. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006
13. Cunningham D, Chua YJ: East meets west in the treatment of gastric cancer. N Engl J Med 357:1863-1865, 2007
14. Macdonald JS, Benedetti J, Smalley S, et al: Chemoradiation of resected gastric cancer: A 10-year follow-up of the phase III trial INT0116 (SWOG 9008). J Clin Oncol 27:205s, 2009 (suppl; abstr 4515)
15. Hundahl SA, Macdonald JS, Benedetti J, et al: Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Ann Surg Oncol 9:278-286, 2002 (Pubitemid 34298633)
16. Peeters KC, Hundahl SA, Kranenbarg EK, et al: Low Maruyama index surgery for gastric cancer: Blinded reanalysis of the Dutch D1-D2 trial. World J Surg 29:1576-1584, 2005 (Pubitemid 41779858)
17. Jansen EP, Boot H, Dubbelman R, et al: Postoperative chemoradiotherapy in gastric cancer: Phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy. Br J Cancer 97:712-716, 2007 (Pubitemid 47396299)
18. Jansen EP, Boot H, Saunders MP, et al: A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 69:1424-1428, 2007 (Pubitemid 350116396)
19. Jansen EP, Boot H, Dubbelman R, et al: Postoperative chemoradiotherapy in gastric cancer: A phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. Ann Oncol 21:530-534, 2010
20. Greene FL: AJCC Cancer Staging Manual (ed 6). New York, NY, Springer-Verlag, 2002
21. Bonenkamp JJ, Hermans J, Sasako M, et al: Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908-914, 1999 (Pubitemid 29141051)
22. Kajitani T: The general rules for the gastric cancer study in surgery and pathology: Part I. Clinical classification. Jpn J Surg 11:127-139, 1981
23. Siewert JR, Kelsen D, Maruyama K: Gastric Cancer Diagnosis and Treatment: An Interactive Training Program. New York, NY, Springer Electronic Media, 2000
24. Japanese Research Society for Gastric Cancer: Japanese Classification of Gastric Carcinoma (English ed 1). Tokyo, Japan, Kanehara, 1995
25. Bollschweiler E, Boettcher K, Hoelscher AH, et al: Preoperative assessment of lymph node metastases in patients with gastric cancer: Evaluation of the Maruyama computer program. Br J Surg 79:156-160, 1992
26. Guadagni S, de Manzoni G, Catarci M, et al: Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer. World J Surg 24:1550-1558, 2000 (Pubitemid 32047286)
27. Kampschöer GH, Maruyama K, van de Velde CJ, et al: Computer analysis in making preoperative decisions: A rational approach to lymph node dissection in gastric cancer patients. Br J Surg 76:905-908, 1989 (Pubitemid 19233272)
28. Klein JP, Moeschberger ML: Survival Analysis Techniques for Censored and Truncated Data: Statistics for Biology and Health (ed 2). New York, NY, Springer, 2003
29. Gianni L, Panzini I, Tassinari D, et al: Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol 12:1178-1180, 2001
30. Mari E, Floriani I, Tinazzi A, et al: Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials - A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11:837-843, 2000
31. Macdonald JS, Benedetti J, Estes N, et al: Postoperative combined radiation and chemotherapy improves disease free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and gastroesophageal junction: Update of the results of Intergroup Study INT-0116 (SWOG 9008). Presented at the Am Soc Clin Oncol 2004 Gastrointestinal Cancers Symposium, January 22-24, 2004 (abstr 6)
32. Kim S, Lim DH, Lee J, et al: An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 63:1279-1285, 2005 (Pubitemid 41628018)